Brought to you by 
Impax Laboratories buys Tower Holdings and Lineage for $700mm
10 Oct 2014
Executive Summary
Impax Laboratories Inc. (drug delivery technology for controlled-release and niche generics, and branded products) paid $700mm for privately held Tower Holdings Inc., which operates through CorePharma LLC and Amedra Pharmaceuticals LLC, and closely held Lineage Therapeutics Inc. PE firm RoundTable Healthcare Partners previously owned both Tower and Lineage.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
-
Drug Delivery
- Controlled Release
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Impax Laboratories buys Tower Holdings and Lineage for $700mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice